Correlation Between Revelation Biosciences and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Revelation Biosciences and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revelation Biosciences and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revelation Biosciences and Virax Biolabs Group, you can compare the effects of market volatilities on Revelation Biosciences and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revelation Biosciences with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revelation Biosciences and Virax Biolabs.
Diversification Opportunities for Revelation Biosciences and Virax Biolabs
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Revelation and Virax is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Revelation Biosciences and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Revelation Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revelation Biosciences are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Revelation Biosciences i.e., Revelation Biosciences and Virax Biolabs go up and down completely randomly.
Pair Corralation between Revelation Biosciences and Virax Biolabs
Given the investment horizon of 90 days Revelation Biosciences is expected to under-perform the Virax Biolabs. In addition to that, Revelation Biosciences is 1.45 times more volatile than Virax Biolabs Group. It trades about -0.17 of its total potential returns per unit of risk. Virax Biolabs Group is currently generating about -0.08 per unit of volatility. If you would invest 218.00 in Virax Biolabs Group on November 18, 2024 and sell it today you would lose (28.00) from holding Virax Biolabs Group or give up 12.84% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Revelation Biosciences vs. Virax Biolabs Group
Performance |
| Timeline |
| Revelation Biosciences |
| Virax Biolabs Group |
Revelation Biosciences and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Revelation Biosciences and Virax Biolabs
The main advantage of trading using opposite Revelation Biosciences and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revelation Biosciences position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.| Revelation Biosciences vs. Virax Biolabs Group | Revelation Biosciences vs. Kiora Pharmaceuticals | Revelation Biosciences vs. ZyVersa Therapeutics | Revelation Biosciences vs. Sonnet Biotherapeutics Holdings |
| Virax Biolabs vs. Revelation Biosciences | Virax Biolabs vs. Kiora Pharmaceuticals | Virax Biolabs vs. Quoin Pharmaceuticals Ltd | Virax Biolabs vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |